In CML, the BCR-ABL gene induces the production of ROS, cause DNA damage and regulate the DNA repair process, which leads to genomic instability, increased gene mutations, and tumor progression [44]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.